Drug & supplement interaction

Fulvic Acid + Osimertinib Mesylate

Osimertinib Mesylate brand name: Tagrisso.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Fulvic Acid and Osimertinib Mesylate in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Fulvic Acid and Osimertinib Mesylate

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Osimertinib Mesylate and Fulvic Acid in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Fulvic Acid safety at a glance

Fulvic Acid overall Use caution Short-term use appears generally tolerated, but high-quality safety data in humans is limited.
Pregnancy Avoid There is not enough safety information, so avoid use during pregnancy.
Breastfeeding Avoid There is not enough safety information, so avoid use while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Osimertinib Mesylate and Fulvic Acid? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Osimertinib Mesylate

Interactions in our licensed database are recorded against drug classes, not just single drug names. Osimertinib Mesylate is filed under 6 classifications — including cytochrome p450 1a2 (cyp1a2) inhibitors, qt interval-prolonging drugs, cytochrome p450 3a4 (cyp3a4) inhibitors. Fulvic Acid has documented interactions with 3 drug classes — the most serious being anticoagulant/antiplatelet drugs (moderate), immunosuppressants (moderate) and thyroid hormone (moderate) — and none of Osimertinib Mesylate’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Fulvic Acid Does Interact With Other Medications

Fulvic Acid has 257 moderate known drug interactions in our database — Osimertinib Mesylate isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Fulvic Acid

Covers the 2,830 medications we’ve checked against Fulvic Acid. Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Fulvic Acid and Osimertinib Mesylate May Share a Side Effect

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do.

  • Diarrhea Additional detail

    Fulvic Acid

    “In one clinical trial, fulvic acid 3.8% 40 mL taken orally twice daily resulted in diarrhea and sore throat in some patients.”

    Fulvic Acid · Natural Medicines adverse-effect record, reported in diarrhea.

    1 source cited
    1. 90589. Gandy JJ, Meeding JP, Snyman JR, et al. Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid. Clin Pharmacol. 2012;4:7-11. PubMed

    Osimertinib Mesylate

    Listed in the ADVERSE REACTIONS section of the FDA label for Osimertinib Mesylate. Read the label on DailyMed ›

Reported for Fulvic Acid but not commonly for Osimertinib Mesylate: sore throat and headache.

Effects for Osimertinib Mesylate come from the ADVERSE REACTIONS section of its FDA label; effects for Fulvic Acid come from the Natural Medicines adverse-effect record, quoted above. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Overlapping uses

What Osimertinib Mesylate Is Prescribed For, and What Fulvic Acid Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Osimertinib Mesylate is a prescription medicine with approved uses on its FDA label. Fulvic Acid is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Osimertinib Mesylate is prescribed for: Tagrisso is used to treat adults with non-small cell lung cancer (NSCLC) whose tumors have specific EGFR mutations — either an exon 19 deletion or an exon 21 L858R mutation — confirmed by an FDA-approved test. It is used in several settings: after surgery to reduce the risk of cancer returning (adjuvant therapy), for locally advanced stage III NSCLC that has not progressed after chemoradiation, and as a first-line treatment for locally advanced or metastatic NSCLC (including in combination with pemetrexed and platinum-based chemotherapy). Tagrisso is also approved for adults with metastatic NSCLC that carries a specific resistance mutation called T790M, when the cancer has stopped responding to another EGFR-targeted therapy.

Fulvic Acid has been studied for:

  • Cancer studied, not established Fulvic Acid has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Fulvic Acid for cancer

    Although there has been interest in using oral fulvic acid for cancer, there is insufficient reliable information about the clinical effects of fulvic acid for this purpose.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Osimertinib Mesylate on your own; if you are taking Fulvic Acid for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

From our Q&A

Questions About Fulvic Acid or Osimertinib Mesylate

These are real questions from readers, answered by the pharmacists at HelloPharmacist — written by a person, not generated from a database. Each one covers Fulvic Acid or Osimertinib Mesylate, not necessarily both, but if one is close to what you were about to ask it will usually go further than a database entry can:

Not quite your question? Ask our pharmacists directly — it is free, there is no account required, and answers usually come back within 24 hours.

Everything else you take

See Every Supplement That Interacts With Osimertinib Mesylate

This page covers Fulvic Acid only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Osimertinib Mesylate page lists 164 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), American Hellebore (major), Arsenic (major), Cesium (major) and Ephedra (major).

By severity: 8 major · 117 moderate · 39 minor.

From our pharmacist’s overview on the Osimertinib Mesylate page

“Osimertinib (Tagrisso) treats EGFR-mutated lung cancer, and this is a list to read carefully before you add anything from the supplement aisle. Of the 164 ingredients on file, most can change how much drug reaches your blood, chiefly through the CYP3A4 enzyme that clears it.”

Reviewed by 2 · Jul 18, 2026

Open the Osimertinib Mesylate interaction page

One more smart check

Taking Fulvic Acid as Part of a Dietary Supplement Product? Check It for Interactions

We hold 294 real supplement products containing Fulvic Acid, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Fulvic Acid. Even though Fulvic Acid itself has no known interaction with Osimertinib Mesylate, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Fulvic Acid and Osimertinib Mesylate Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Fulvic Acid
Top half

#388 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Osimertinib Mesylate
Top 25%

#445 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Fulvic Acid reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 27, 2026. The Fulvic Acid and Osimertinib Mesylate records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Fulvic Acid

What is Fulvic Acid?

  • General wellness and energy
  • Gut health
  • Antioxidant support
  • Mineral and nutrient supplementation
  • Immune support

Fulvic acid is a natural compound formed when plants and microbes break down in soil, and it is sold as a supplement for energy, gut, and overall wellness. Human research is very limited, so most claims are unproven. Talk with your pharmacist or doctor before using it, and avoid it during pregnancy and breastfeeding due to a lack of safety data.

Derived from humus, soil, peat, and decomposed plant matter (often sourced from shilajit or leonardite) · Liquid drops, capsules, powders, shilajit resin, mineral supplements

An interaction check asks whether these two react with each other — it does not ask whether Fulvic Acid is a good idea for someone in your situation. Here is what our Fulvic Acid record says about it on its own.

Fulvic Acid: dosing

There is no official or standardized dose for fulvic acid. Products vary widely in concentration and form, including drops, capsules, and powders.The safest approach is to follow the directions on the product label and start with the lowest suggested amount.

From our Fulvic Acid monograph — the full record covers uses, side effects and every documented interaction.

Read the full Fulvic Acid monograph & all interactions
Medication

About Osimertinib

What Is Osimertinib Used For?

Brand name: Tagrisso

Tagrisso is used to treat adults with non-small cell lung cancer (NSCLC) whose tumors have specific EGFR mutations — either an exon 19 deletion or an exon 21 L858R mutation — confirmed by an FDA-approved test. It is used in several settings: after surgery to reduce the risk of cancer returning (adjuvant therapy), for locally advanced stage III NSCLC that has not progressed after chemoradiation, and as a first-line treatment for locally advanced or metastatic NSCLC (including in combination with pemetrexed and platinum-based chemotherapy).

Tagrisso is also approved for adults with metastatic NSCLC that carries a specific resistance mutation called T790M, when the cancer has stopped responding to another EGFR-targeted therapy.

See full Osimertinib drug information
Keep checking

Other Drugs & Fulvic Acid

Browse every other medication we’ve checked against Fulvic Acid — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
257Moderate
0Minor
2,572No known interaction
Moderate

257 interactions

Showing 60 of 257 moderate interactions — see all 257 on the Fulvic Acid page.

No interaction 2,572 drugs checked — show the list

We also checked Fulvic Acid against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,572 medications checked with no known interaction — see the full Fulvic Acid list.

Evidence & sources

Fulvic Acid References

The 3 references that drive our Fulvic Acid monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Lu, FJ. Arsenic as a promoter in the effect of humic substances on plasma prothrombin time in vitro. Thromb Res 6-15-1990;58(6):537-541. PubMed
  2. Vucskits, AV, Hullar, I, Bersenyi, A, Andrasofszky, E, Kulcsar, M, Szabo, J. Effect of fulvic and humic acids on performance, immune response and thyroid function in rats. J Anim Physiol Anim Nutr (Berl) 2010;94(6):721-728. PubMed
  3. Gandy JJ, Meeding JP, Snyman JR, et al. Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid. Clin Pharmacol. 2012;4:7-11. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Fulvic Acid and Osimertinib Mesylate Together: Common Questions

Is it safe to take Fulvic Acid with Osimertinib Mesylate?
We do not list a known interaction between Fulvic Acid and Osimertinib Mesylate. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Fulvic Acid and Osimertinib Mesylate have any of the same side effects?
Yes — our sources link each of them separately to one of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Are Fulvic Acid and Osimertinib Mesylate used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Fulvic Acid in each. That is a conversation for your prescriber, especially if Osimertinib Mesylate is being adjusted to a target.
How was the Fulvic Acid and Osimertinib Mesylate combination checked?
Interactions in our licensed database are recorded against drug classes. Osimertinib Mesylate is filed under 6 classifications, and Fulvic Acid has documented interactions with 3 drug classes — none of Osimertinib Mesylate's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Fulvic Acid interact with any other medications?
Yes. Fulvic Acid has 257 documented drug interactions in our database — Osimertinib Mesylate is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Osimertinib Mesylate interact with any supplements?
Yes. Osimertinib Mesylate has documented interactions with 164 supplements in our database — Fulvic Acid is not one of them. The Osimertinib Mesylate interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Osimertinib Mesylate and Fulvic Acid?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.